$27.60
-1.16-4.03%
al cierre: Nov 20, 4:00 PM EST
$27.60
N/A
After hour: Nov 20, 4:00 PM EST

Agios Pharmaceuticals (AGIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.09 | $-1.25 | 12.8 % |
| Q2 | Jul 30, 2026 | $-1.69 | $-1.71 | 1.17 % |
| Q1 | Apr 29, 2026 | $-1.69 | $-1.79 | 5.59 % |
| Q4 | Feb 12, 2026 | $-1.86 | $-1.96 | 5.10 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $55.39M | $50.12M | 10.5 % |
| Q2 | Jul 30, 2026 | $44.75M | $25.64M | 74.5 % |
| Q1 | Apr 29, 2026 | $20.75M | $13.83M | 50.0 % |
| Q4 | Feb 12, 2026 | $19.97M | $11.35M | 75.9 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.25 | $-1.71 | $-1.79 | $-1.96 |
| Actual | $-1.09 | $-1.69 | $-1.69 | $-1.86 |
| Surprise | +12.8% | +1.17% | +5.59% | +5.10% |
| Revenue | ||||
| Estimate | $50.1M | $25.6M | $13.8M | $11.4M |
| Actual | $55.4M | $44.7M | $20.7M | $20.0M |
| Surprise | +10.5% | +74.5% | +50.0% | +75.9% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.09 | $-0.74 | $-1.21 | $-1.17 |
| Revenue | ||||
| Consensus | $61.8M | $63.1M | — | — |